《大行報告》花旗下調互太紡織(01382.HK)目標價至7元 評級「買入」
花旗發表研究報告指,由於原材料成本上漲,導致互太紡織(01382.HK)2021下半財年毛利率僅錄15%,表現遜預期。該行相應將2022至2023財年盈利預測下調19%及16%,目標價由8元降至7元。
該行估計,銷售均價回升需要一段時間反映,2022財年毛利率料回升至16%至16.5%。基於目前訂單情況及售價升勢,公司目標收入可增長10%至60億元,核心盈利料錄高單位數增長至6.6億至7億元。
花旗指出,互太紡織現價相當於2022財年預測市盈率的10至11倍,屬較便宜,加上公司維持派息比率達84%,未來派息比率料達80%至90%,股息率超過8%,維持「買入」評級。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.